You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

PENTETATE ZINC TRISODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pentetate Zinc Trisodium patents expire, and what generic alternatives are available?

Pentetate Zinc Trisodium is a drug marketed by Hameln Pharma Plus and is included in one NDA.

The generic ingredient in PENTETATE ZINC TRISODIUM is pentetate zinc trisodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the pentetate zinc trisodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PENTETATE ZINC TRISODIUM?
  • What are the global sales for PENTETATE ZINC TRISODIUM?
  • What is Average Wholesale Price for PENTETATE ZINC TRISODIUM?
Summary for PENTETATE ZINC TRISODIUM
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 13
Clinical Trials: 1
Patent Applications: 24
What excipients (inactive ingredients) are in PENTETATE ZINC TRISODIUM?PENTETATE ZINC TRISODIUM excipients list
DailyMed Link:PENTETATE ZINC TRISODIUM at DailyMed
Drug patent expirations by year for PENTETATE ZINC TRISODIUM
Recent Clinical Trials for PENTETATE ZINC TRISODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 1/Phase 2

See all PENTETATE ZINC TRISODIUM clinical trials

Pharmacology for PENTETATE ZINC TRISODIUM
Drug ClassLead Chelator
Mechanism of ActionLead Chelating Activity

US Patents and Regulatory Information for PENTETATE ZINC TRISODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hameln Pharma Plus PENTETATE ZINC TRISODIUM pentetate zinc trisodium SOLUTION;INHALATION, INTRAVENOUS 021751-001 Aug 11, 2004 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.